Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice

被引:458
作者
Tong, Xiaoping [1 ]
Ao, Yan [2 ]
Faas, Guido C. [3 ]
Nwaobi, Sinifunanya E. [4 ]
Xu, Ji [1 ]
Haustein, Martin D. [1 ]
Anderson, Mark A. [2 ]
Mody, Istvan [1 ,3 ]
Olsen, Michelle L. [4 ]
Sofroniew, Michael V. [2 ]
Khakh, Baljit S. [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
[4] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA
基金
美国国家卫生研究院;
关键词
CENTRAL-NERVOUS-SYSTEM; RECTIFYING K+ CHANNEL; MUTANT HUNTINGTIN; TRANSGENIC MICE; NEUROLOGICAL SYMPTOMS; IN-VIVO; STRIATAL ASTROCYTES; GLUTAMATE TRANSPORT; KNOCK-OUT; EXPRESSION;
D O I
10.1038/nn.3691
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is characterized by striatal medium spiny neuron (MSN) dysfunction, but the underlying mechanisms remain unclear. We explored roles for astrocytes, in which mutant huntingtin is expressed in HD patients and mouse models. We found that symptom onset in R6/2 and Q175 HD mouse models was not associated with classical astrogliosis, but was associated with decreased Kir4.1 K+ channel functional expression, leading to elevated in vivo striatal extracellular K+, which increased MSN excitability in vitro. Viral delivery of Kir4.1 channels to striatal astrocytes restored Kir4.1 function, normalized extracellular K+, ameliorated aspects of MSN dysfunction, prolonged survival and attenuated some motor phenotypes in R6/2 mice. These findings indicate that components of altered MSN excitability in HD may be caused by heretofore unknown disturbances of astrocyte-mediated K+ homeostasis, revealing astrocytes and Kir4.1 channels as therapeutic targets.
引用
收藏
页码:694 / +
页数:12
相关论文
共 50 条
[1]   Electrophysiological properties and gap junction coupling of striatal astrocytes [J].
Adermark, Louise ;
Lovinger, David M. .
NEUROCHEMISTRY INTERNATIONAL, 2008, 52 (07) :1365-1372
[2]   The functional significance of K-complexes [J].
Amzica, F ;
Steriade, M .
SLEEP MEDICINE REVIEWS, 2002, 6 (02) :139-149
[3]   Neuronal vulnerability in mouse models of Huntington's disease: Membrane channel protein changes [J].
Ariano, MA ;
Wagle, N ;
Grissell, AE .
JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 80 (05) :634-645
[4]   Striatal potassium channel dysfunction in Huntington's disease transgenic mice [J].
Ariano, MA ;
Cepeda, C ;
Calvert, CR ;
Flores-Hernández, J ;
Hernández-Echeagaray, E ;
Klapstein, GJ ;
Chandler, SH ;
Aronin, N ;
DiFiglia, M ;
Levine, MS .
JOURNAL OF NEUROPHYSIOLOGY, 2005, 93 (05) :2565-2574
[5]  
BARRES BA, 1991, ANN NY ACAD SCI, V633, P248
[6]   ION CHANNEL EXPRESSION BY WHITE MATTER GLIA - THE TYPE-1 ASTROCYTE [J].
BARRES, BA ;
KOROSHETZ, WJ ;
CHUN, LLY ;
COREY, DP .
NEURON, 1990, 5 (04) :527-544
[7]   The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease [J].
Barres, Ben A. .
NEURON, 2008, 60 (03) :430-440
[8]   Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation [J].
Behrens, P. F. ;
Franz, P. ;
Woodman, B. ;
Lindenberg, K. S. ;
Landwehrmeyer, G. B. .
BRAIN, 2002, 125 :1908-1922
[9]   Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease [J].
Benn, Caroline L. ;
Fox, Helen ;
Bates, Gillian P. .
MOLECULAR NEURODEGENERATION, 2008, 3 (1)
[10]   Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice [J].
Bradford, Jennifer ;
Shin, Ji-Yeon ;
Roberts, Meredith ;
Wang, Chuan-En ;
Sheng, Guoqing ;
Li, Shihua ;
Li, Xiao-Jiang .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (14) :10653-10661